Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
We describe a chemical proteomics approach to profile the interaction of small molecules
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
[PDF][PDF] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham… - NATURE …, 2007 - researchgate.net
RESULTS Target profiling with immobilized kinase inhibitors Affinity purification strategies
combined with MS-based protein identification enable the identification of potential drug …
combined with MS-based protein identification enable the identification of potential drug …
[引用][C] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham, S Bastuck… - Nature …, 2007 - cir.nii.ac.jp
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase
inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham… - Nature …, 2007 - pubmed.ncbi.nlm.nih.gov
We describe a chemical proteomics approach to profile the interaction of small molecules
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
[PDF][PDF] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham… - NATURE …, 2007 - academia.edu
RESULTS Target profiling with immobilized kinase inhibitors Affinity purification strategies
combined with MS-based protein identification enable the identification of potential drug …
combined with MS-based protein identification enable the identification of potential drug …
[引用][C] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M BANTSCHEFF, D EBERHARD… - Nature …, 2007 - pascal-francis.inist.fr
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham, S Bastuck… - Nature …, 2007 - go.gale.com
We describe a chemical proteomics approach to profile the interaction of small molecules
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
M Bantscheff, D Eberhard, Y Abraham… - Nature …, 2007 - search.ebscohost.com
We describe a chemical proteomics approach to profile the interaction of small molecules
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
M Bantscheff, D Eberhard, Y Abraham… - Nature …, 2007 - europepmc.org
We describe a chemical proteomics approach to profile the interaction of small molecules
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
with hundreds of endogenously expressed protein kinases and purine-binding proteins. This …
[PDF][PDF] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
M Bantscheff, D Eberhard, Y Abraham… - NATURE …, 2007 - academia.edu
RESULTS Target profiling with immobilized kinase inhibitors Affinity purification strategies
combined with MS-based protein identification enable the identification of potential drug …
combined with MS-based protein identification enable the identification of potential drug …